A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer
Abstract Background Cisplatin-induced hearing loss is frequent and severe. Antioxidants such as sodium thiosulfate (STS) can neutralize the effects of cisplatin. The objective of the trial was to test the efficacy of trans-tympanic injections of a STS gel to prevent cisplatin-induced ototoxicity. Me...
Saved in:
| Main Authors: | Viannique Rolland, François Meyer, Matthieu J. Guitton, Richard Bussières, Daniel Philippon, Isabelle Bairati, Mathieu Leclerc, Mathieu Côté |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2019-01-01
|
| Series: | Journal of Otolaryngology - Head and Neck Surgery |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s40463-019-0327-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Local application of sodium thiosulfate as an otoprotectant for cisplatin-exposed patients – A narrative literature review to explore the potential benefit for children with cancer
by: Nienke Streefkerk, et al.
Published: (2025-06-01) -
Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin
by: Tatpong Sriyapai, et al.
Published: (2022-06-01) -
Strategies to Mitigate Cisplatin-Induced Ototoxicity: A Literature Review of Protective Agents, Mechanisms, and Clinical Gaps
by: Alexandru Orasan, et al.
Published: (2025-02-01) -
New application of ombuoside in protecting auditory cells from cisplatin-induced ototoxicity via the apoptosis pathway
by: Xingxing Wu, et al.
Published: (2024-10-01) -
Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy
by: Nesrine Benkafadar, et al.
Published: (2016-10-01)